skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 351  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review
Material Type:
Article
Add to My Research

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review

Diabetes, obesity & metabolism, 2018-02, Vol.20 (2), p.427

ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.13088

Digital Resources/Online E-Resources

2
Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes
Material Type:
Article
Add to My Research

Effects of empagliflozin on blood pressure and markers of arterial stiffness and vascular resistance in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2015-12, Vol.17 (12), p.1180-1193

2015 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;2015 John Wiley & Sons Ltd ;2015. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12572 ;PMID: 26343814 ;CODEN: DOMEF6

Full text available

3
Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study
Material Type:
Article
Add to My Research

Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study

Diabetes, obesity & metabolism, 2016-09, Vol.18 (9), p.907-915

2016 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;2016 John Wiley & Sons Ltd ;2016. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1462-8902 ;ISSN: 1463-1326 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12689 ;PMID: 27161418 ;CODEN: DOMEF6

Full text available

4
Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes
Material Type:
Article
Add to My Research

Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes

Diabetes, obesity & metabolism, 2012-09, Vol.14 (9), p.859-864

2012 Blackwell Publishing Ltd ;2012 Blackwell Publishing Ltd. ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/j.1463-1326.2012.01627.x ;PMID: 22594461

Full text available

5
Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists
Material Type:
Article
Add to My Research

Review of head-to-head comparisons of glucagon-like peptide-1 receptor agonists

Diabetes, obesity & metabolism, 2016-04, Vol.18 (4), p.317-332

2015 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;2016 John Wiley & Sons Ltd ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12596 ;PMID: 26511102 ;CODEN: DOMEF6

Full text available

6
New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
Material Type:
Article
Add to My Research

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

Diabetes, obesity & metabolism, 2015-04, Vol.17 (4), p.386-394

2015 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;2015 John Wiley & Sons Ltd ;2015. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. 2015 ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12438 ;PMID: 25641260 ;CODEN: DOMEF6

Full text available

7
Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐Analysis
Material Type:
Article
Add to My Research

Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta‐Analysis

The oncologist (Dayton, Ohio), 2012, Vol.17 (6), p.813-822 [Peer Reviewed Journal]

2012 AlphaMed Press ;AlphaMed Press 2012 ;ISSN: 1083-7159 ;EISSN: 1549-490X ;DOI: 10.1634/theoncologist.2011-0462 ;PMID: 22643536

Full text available

8
Diabetes and Cancer: A Consensus Report
Material Type:
Article
Add to My Research

Diabetes and Cancer: A Consensus Report

CA: a cancer journal for clinicians, 2010-07, Vol.60 (4), p.207-221 [Peer Reviewed Journal]

Copyright © 2010 American Cancer Society, Inc. ;(c) 2010 American Cancer Society, Inc. ;Copyright Lippincott Williams & Wilkins Jul/Aug 2010 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.20078 ;PMID: 20554718 ;CODEN: CAMCAM

Full text available

9
Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients
Material Type:
Article
Add to My Research

Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients

Journal of the American Heart Association, 2017-05, Vol.6 (6) [Peer Reviewed Journal]

2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. ;ISSN: 2047-9980 ;EISSN: 2047-9980 ;DOI: 10.1161/JAHA.116.004007 ;PMID: 28546454

Full text available

10
Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium–glucose cotransporter 2 inhibitor and metformin in healthy subjects
Material Type:
Article
Add to My Research

Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium–glucose cotransporter 2 inhibitor and metformin in healthy subjects

British journal of clinical pharmacology, 2023-04, Vol.89 (4), p.1462-1470 [Peer Reviewed Journal]

2022 British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.15613 ;PMID: 36422809

Full text available

11
MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study
Material Type:
Article
Add to My Research

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

British journal of clinical pharmacology, 2018-10, Vol.84 (10), p.2325-2335 [Peer Reviewed Journal]

2018 The British Pharmacological Society ;2018 The British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.13688 ;PMID: 29926478

Full text available

12
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
Material Type:
Article
Add to My Research

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

International journal of clinical practice (Esher), 2013-12, Vol.67 (12), p.1267-1282 [Peer Reviewed Journal]

2013 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd ;2013 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd. ;Copyright © 2013 John Wiley & Sons Ltd ;2013 The Authors International Journal of Clinical Practice Published by John Wiley & Sons Ltd 2013 ;ISSN: 1368-5031 ;EISSN: 1742-1241 ;DOI: 10.1111/ijcp.12322 ;PMID: 24118688

Full text available

13
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone
Material Type:
Article
Add to My Research

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone

Diabetes, obesity & metabolism, 2014-05, Vol.16 (5), p.467-477

2014 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. ;2014. This article is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. 2014 ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.12273 ;PMID: 24528605 ;CODEN: DOMEF6

Full text available

14
LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial
Material Type:
Article
Add to My Research

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo-Controlled Trial

Clinical pharmacology and therapeutics, 2012-08, Vol.92 (2), p.158-169 [Peer Reviewed Journal]

2012 American Society for Clinical Pharmacology and Therapeutics ;2015 INIST-CNRS ;Copyright © 2012 American Society of Clinical Pharmacology and Therapeutics 2012 American Society of Clinical Pharmacology and Therapeutics ;ISSN: 0009-9236 ;EISSN: 1532-6535 ;DOI: 10.1038/clpt.2012.58 ;PMID: 22739142 ;CODEN: CLPTAT

Full text available

15
Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
Material Type:
Article
Add to My Research

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis

British journal of clinical pharmacology, 2022-01, Vol.88 (1), p.311-322 [Peer Reviewed Journal]

2021 The Authors. published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. ;ISSN: 0306-5251 ;EISSN: 1365-2125 ;DOI: 10.1111/bcp.14970 ;PMID: 34198358

Full text available

16
Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes
Material Type:
Article
Add to My Research

Organic cation transporter 1 variants and gastrointestinal side effects of metformin in patients with Type 2 diabetes

Diabetic medicine, 2016-04, Vol.33 (4), p.511-514 [Peer Reviewed Journal]

2016 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. ;2015 Diabetes UK. ;ISSN: 0742-3071 ;EISSN: 1464-5491 ;DOI: 10.1111/dme.13040 ;PMID: 26605869 ;CODEN: DIMEEV

Full text available

17
Metformin in pregnancy: a re‐examination of its safety
Material Type:
Article
Add to My Research

Metformin in pregnancy: a re‐examination of its safety

The Journal of physiology, 2022-02, Vol.600 (4), p.705-706 [Peer Reviewed Journal]

2021 The Authors. The Journal of Physiology © 2021 The Physiological Society ;Journal compilation © 2022 The Physiological Society ;ISSN: 0022-3751 ;EISSN: 1469-7793 ;DOI: 10.1113/JP282324 ;PMID: 34762307

Full text available

18
Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes
Material Type:
Article
Add to My Research

Albiglutide in patients with type 2 diabetes and heart failure: a post‐hoc analysis from Harmony Outcomes

European journal of heart failure, 2022-10, Vol.24 (10), p.1792-1801 [Peer Reviewed Journal]

Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.2660 ;PMID: 36053803

Digital Resources/Online E-Resources

19
Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors
Material Type:
Article
Add to My Research

Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors

Journal of diabetes investigation, 2016-03, Vol.7 (2), p.135-138 [Peer Reviewed Journal]

2015 The Authors. Journal of Diabetes Investigation published by Asian Association of the Study of Diabetes (AASD) and Wiley Publishing Asia Pty Ltd ;2016. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2040-1116 ;EISSN: 2040-1124 ;DOI: 10.1111/jdi.12401 ;PMID: 27042263

Full text available

20
Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24-week, randomized, double-blind, placebo-controlled, dose-ranging phase 2b trial
Material Type:
Article
Add to My Research

Efficacy and safety of imeglimin in Japanese patients with type 2 diabetes: A 24-week, randomized, double-blind, placebo-controlled, dose-ranging phase 2b trial

Diabetes, obesity & metabolism, 2021-03, Vol.23 (3), p.800-810

Attribution - NonCommercial - NoDerivatives ;ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/dom.14285

Digital Resources/Online E-Resources

Results 1 - 20 of 351  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (290)

Refine My Results

Creation Date 

From To
  1. Before 2001  (11)
  2. 2001 To 2005  (12)
  3. 2006 To 2010  (34)
  4. 2011 To 2016  (173)
  5. After 2016  (122)
  6. More options open sub menu

Language 

  1. Japanese  (43)
  2. Russian  (2)
  3. More options open sub menu

Searching Remote Databases, Please Wait